Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Boyd

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Expert Opinion on Pharmacotherapy|May 3, 2007
Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?Mark Boyd
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 19, 2008
Renal Artery Intervention - an Invasive Radiologist's ApproachMikael Sylve'n, Mark Boyd
The American Journal of Tropical Medicine and Hygiene|January 27, 2007
Co-infections in an HIV-infected man from MalawiThomas Snelling, Chris Ossowicz, Mark Boyd
The Medical Journal of Australia|November 23, 2006
Pandemic influenza: clinical issuesMark Boyd, Kate Clezy, Richard Lindley, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 7, 2006
Metastatic adenocarcinoma mimicking 'target sign' of cerebral tuberculosisAndrew Kong, Adam Koukourou, Mark Boyd, et al.
SSM - Population Health|March 22, 2022
Can social risks in early life predict children's health and academic outcomes? An analysis of the Longitudinal Study of Australian ChildrenAlexandra Walls, Mark Boyd, Gai McMichael, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2010
Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trialsDianne Carey, Janaki Amin, Mark Boyd, et al.
Lancet (London, England)|August 28, 2015
Tumour metabolism in squamous cell carcinoma of the head and neck: an in-vitro study of the consequences of TP53 mutation and therapeutic implicationsMark Wilkie, Andrew Lau, Nikolina Vlatkovic, et al.
BMJ Open|November 29, 2024
Health Navigator intervention to address the unmet social needs of populations living with cancer attending outpatient treatment at a major metropolitan hospital in Australia: protocol for a mixed-methods feasibility trialKate Neadley, Annabel Smith, Sean Martin, et al.
European Journal of Pediatrics|March 1, 2024
In-person versus electronic screening for social risks among carers of pediatric inpatients: A mixed methods randomized trialLisa Gaye Smithers, Catherine MacPhail, Lily Chan, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|May 3, 2007
Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?Mark Boyd
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 19, 2008
Renal Artery Intervention - an Invasive Radiologist's ApproachMikael Sylve'n, Mark Boyd
The American Journal of Tropical Medicine and Hygiene|January 27, 2007
Co-infections in an HIV-infected man from MalawiThomas Snelling, Chris Ossowicz, Mark Boyd
The Medical Journal of Australia|November 23, 2006
Pandemic influenza: clinical issuesMark Boyd, Kate Clezy, Richard Lindley, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 7, 2006
Metastatic adenocarcinoma mimicking 'target sign' of cerebral tuberculosisAndrew Kong, Adam Koukourou, Mark Boyd, et al.
SSM - Population Health|March 22, 2022
Can social risks in early life predict children's health and academic outcomes? An analysis of the Longitudinal Study of Australian ChildrenAlexandra Walls, Mark Boyd, Gai McMichael, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2010
Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trialsDianne Carey, Janaki Amin, Mark Boyd, et al.
Lancet (London, England)|August 28, 2015
Tumour metabolism in squamous cell carcinoma of the head and neck: an in-vitro study of the consequences of TP53 mutation and therapeutic implicationsMark Wilkie, Andrew Lau, Nikolina Vlatkovic, et al.
BMJ Open|November 29, 2024
Health Navigator intervention to address the unmet social needs of populations living with cancer attending outpatient treatment at a major metropolitan hospital in Australia: protocol for a mixed-methods feasibility trialKate Neadley, Annabel Smith, Sean Martin, et al.
European Journal of Pediatrics|March 1, 2024
In-person versus electronic screening for social risks among carers of pediatric inpatients: A mixed methods randomized trialLisa Gaye Smithers, Catherine MacPhail, Lily Chan, et al.
Pageof 5